Peripheral Artery Disease Market 2023
Emergence of advanced interventional products and enhanced healthcare infrastructure in developing nations drive the growth of the global market.
PORTLAND, OREGON, UNITED STATES, May 17, 2023 /EINPresswire.com/ — Allied Market Research published a report, titled, “๐๐๐ซ๐ข๐ฉ๐ก๐๐ซ๐๐ฅ ๐๐ซ๐ญ๐๐ซ๐ฒ ๐๐ข๐ฌ๐๐๐ฌ๐ ๐๐๐ซ๐ค๐๐ญ ๐๐ฒ ๐๐ฒ๐ฉ๐ (๐๐๐ซ๐ข๐ฉ๐ก๐๐ซ๐๐ฅ ๐๐ง๐ ๐ข๐จ๐ฉ๐ฅ๐๐ฌ๐ญ๐ฒ ๐๐๐ฅ๐ฅ๐จ๐จ๐ง๐ฌ, ๐๐๐ซ๐ข๐ฉ๐ก๐๐ซ๐๐ฅ ๐๐ญ๐๐ง๐ญ๐ฌ, ๐๐๐ซ๐ข๐ฉ๐ก๐๐ซ๐๐ฅ ๐๐๐ญ๐ก๐๐ญ๐๐ซ๐ฌ, ๐๐ง๐๐๐ซ๐ข๐จ๐ซ ๐๐๐ง๐ ๐๐๐ฏ๐ (๐๐๐) ๐ ๐ข๐ฅ๐ญ๐๐ซ๐ฌ, ๐๐ฅ๐๐ช๐ฎ๐ ๐๐จ๐๐ข๐๐ข๐๐๐ญ๐ข๐จ๐ง ๐๐๐ฏ๐ข๐๐๐ฌ, ๐๐๐ฆ๐จ๐๐ฒ๐ง๐๐ฆ๐ข๐ ๐ ๐ฅ๐จ๐ฐ ๐๐ฅ๐ญ๐๐ซ๐๐ญ๐ข๐จ๐ง ๐๐๐ฏ๐ข๐๐๐ฌ, ๐๐ง๐ ๐๐๐ซ๐ข๐ฉ๐ก๐๐ซ๐๐ฅ ๐๐๐๐๐ฌ๐ฌ๐จ๐ซ๐ข๐๐ฌ): ๐๐ฅ๐จ๐๐๐ฅ ๐๐ฉ๐ฉ๐จ๐ซ๐ญ๐ฎ๐ง๐ข๐ญ๐ฒ ๐๐ง๐๐ฅ๐ฒ๐ฌ๐ข๐ฌ ๐๐ง๐ ๐๐ง๐๐ฎ๐ฌ๐ญ๐ซ๐ฒ ๐ ๐จ๐ซ๐๐๐๐ฌ๐ญ, ๐๐๐๐โ๐๐๐๐.” The report provides a detailed analysis of the top investment pockets, top winning strategies, drivers & opportunities, market size & estimations, competitive landscape, and evolving market trends. The market study is a helpful source of information for the frontrunners, new entrants, investors, and shareholders in crafting strategies for the future and heightening their position in the market.
The global Peripheral Artery Disease Market Size Was Valued at USD 3.52 billion in 2019 and it is estimated to surpass around USD 5.71 billion by 2027, with a registered CAGR of 8.5% from 2020 to 2027.
๐๐จ๐ฏ๐ข๐-๐๐ ๐๐๐๐ง๐๐ซ๐ข๐จ
โข Many health governing bodies have circulated guidelines regarding operating PDA during the Covid-19 pandemic. The American College of Surgeons (ACS) released guidelines for triage of vascular surgery patients. These guidelines suggest that non-emergency peripheral vascular procedures should be postponed.
โข In many regions that have been affected considerably by the pandemic, government directives or hospital guidelines have restricted vascular procedures to life or limb-salvaging cases only.
โข Production interruptions of PAD devices and delays in procedures from hospitals due to COVID-19 pandemic is expected to effect the growth of Peripheral Artery Disease Market.”
๐๐๐ญ ๐๐๐ฆ๐ฉ๐ฅ๐ ๐๐๐ ๐๐๐ฉ๐จ๐ซ๐ญ ๐ฐ๐ข๐ญ๐ก ๐๐ซ๐๐ฉ๐ก๐ฌ ๐๐ง๐ ๐ ๐ข๐ ๐ฎ๐ซ๐๐ฌ ๐๐๐ซ๐: https://www.alliedmarketresearch.com/request-sample/4315
๐๐ฆ๐๐ซ๐ ๐๐ง๐๐ ๐จ๐ ๐๐๐ฏ๐๐ง๐๐๐ ๐ข๐ง๐ญ๐๐ซ๐ฏ๐๐ง๐ญ๐ข๐จ๐ง๐๐ฅ ๐ฉ๐ซ๐จ๐๐ฎ๐๐ญ๐ฌ, ๐๐ง๐ก๐๐ง๐๐๐ ๐ก๐๐๐ฅ๐ญ๐ก๐๐๐ซ๐ ๐ข๐ง๐๐ซ๐๐ฌ๐ญ๐ซ๐ฎ๐๐ญ๐ฎ๐ซ๐ ๐ข๐ง ๐๐๐ฏ๐๐ฅ๐จ๐ฉ๐ข๐ง๐ ๐ง๐๐ญ๐ข๐จ๐ง๐ฌ, ๐๐ง๐ ๐ฌ๐ฎ๐ฉ๐ฉ๐จ๐ซ๐ญ๐ข๐ฏ๐ ๐ข๐ง๐ฌ๐ฎ๐ซ๐๐ง๐๐ ๐๐ง๐ ๐ซ๐๐ข๐ฆ๐๐ฎ๐ซ๐ฌ๐๐ฆ๐๐ง๐ญ ๐ฉ๐จ๐ฅ๐ข๐๐ข๐๐ฌ ๐๐ซ๐ข๐ฏ๐ ๐ญ๐ก๐ ๐ ๐ซ๐จ๐ฐ๐ญ๐ก ๐จ๐ ๐ญ๐ก๐ ๐ ๐ฅ๐จ๐๐๐ฅ ๐ฉ๐๐ซ๐ข๐ฉ๐ก๐๐ซ๐๐ฅ ๐๐ซ๐ญ๐๐ซ๐ฒ ๐๐ข๐ฌ๐๐๐ฌ๐ ๐ฆ๐๐ซ๐ค๐๐ญ. ๐๐จ๐ฐ๐๐ฏ๐๐ซ, ๐ฌ๐ญ๐ซ๐ข๐๐ญ ๐๐ฉ๐ฉ๐ซ๐จ๐ฏ๐๐ฅ ๐ฉ๐ซ๐จ๐๐๐ฌ๐ฌ ๐๐จ๐ซ ๐ฌ๐ญ๐๐ง๐ญ๐ฌ ๐ก๐ข๐ง๐๐๐ซ๐ฌ ๐ญ๐ก๐ ๐ฆ๐๐ซ๐ค๐๐ญ ๐ ๐ซ๐จ๐ฐ๐ญ๐ก. ๐๐ง ๐ญ๐ก๐ ๐จ๐ญ๐ก๐๐ซ ๐ก๐๐ง๐, ๐ฎ๐ง๐ญ๐๐ฉ๐ฉ๐๐ ๐ฉ๐จ๐ญ๐๐ง๐ญ๐ข๐๐ฅ ๐ข๐ง ๐๐๐ฏ๐๐ฅ๐จ๐ฉ๐ข๐ง๐ ๐ง๐๐ญ๐ข๐จ๐ง๐ฌ ๐๐ซ๐๐๐ญ๐ ๐ง๐๐ฐ ๐จ๐ฉ๐ฉ๐จ๐ซ๐ญ๐ฎ๐ง๐ข๐ญ๐ข๐๐ฌ ๐ข๐ง ๐ญ๐ก๐ ๐๐จ๐ฆ๐ข๐ง๐ ๐ฒ๐๐๐ซ๐ฌ.
๐๐๐ซ๐ข๐ฉ๐ก๐๐ซ๐๐ฅ ๐๐ซ๐ญ๐๐ซ๐ฒ ๐๐ข๐ฌ๐๐๐ฌ๐ ๐๐จ๐ฆ๐ฉ๐๐ง๐ข๐๐ฌ: –
โข Abbott Laboratories
โข Boston Scientific Corporation
โข Cook Medical
โข Cardinal Health, Inc.
โข Becton, Dickinson and Company
โข Terumo Corporation
โข Koninklijke Philips N.V
โข AngioDynamics, Inc.
โข BIOTRONIK
โข B. Braun Melsungen AG
๐๐ฅ๐จ๐๐๐ฅ ๐๐๐ข๐จ๐ฉ๐๐ญ๐ก๐ข๐ ๐๐ฎ๐ฅ๐ฆ๐จ๐ง๐๐ซ๐ฒ ๐ ๐ข๐๐ซ๐จ๐ฌ๐ข๐ฌ ๐๐๐ซ๐ค๐๐ญ ๐๐๐ ๐ฆ๐๐ง๐ญ๐๐ญ๐ข๐จ๐ง: โ
Based on type, the peripheral stents segment contributed to the largest market share, holding nearly two-fifths of the total share of the global peripheral artery disease market in 2019, and is expected to maintain its highest contribution during the forecast period. This is attributed to technological innovations leading to development of bio-engineered stents, dual therapy stents, and EPC capture stents. However, the plaque modification devices segment is expected to grow at the largest CAGR of 9.5% from 2020 to 2027. This is due to necessity of these devices while ballooning of arteries fail.
Based on region, North America accounted for the highest share in terms of revenue, contributing to nearly two-fifths of the global peripheral artery disease market in 2019, and will maintain its lead position during the forecast period. This is due to changes in lifestyle habits such as unhealthy dietary habits, smoking, excessive alcohol consumption, and lack of physical activity of people in the region. However, Asia-Pacific is expected to grow at the highest CAGR of 9.4% from 2020 to 2027, owing to expansion of healthcare budgets, rise in disposable income, and surge in demand for technologically advanced devices.
๐๐ฎ๐ซ๐๐ก๐๐ฌ๐ ๐ญ๐ก๐ ๐๐๐ฉ๐จ๐ซ๐ญ: https://www.alliedmarketresearch.com/purchase-enquiry/4315
Key Benefits For Stakeholders
โข The study provides an in-depth analysis of the peripheral artery disease market along with current trends and future estimations to elucidate the imminent investment pockets.
โข It offers a quantitative analysis from 2022 to 2032, which is expected to enable stakeholders to capitalize on prevailing peripheral artery disease market opportunities.
โข The key market players and their strategies have been analyzed to understand the competitive outlook of the peripheral artery disease market.
Our Market Research Solution Provides You Answer to Below Mentioned Question:
โข Which are the driving factors responsible for the growth of market?
โข Which are the roadblock factors of this market?
โข What are the new opportunities, by which market will grow in coming years?
โข What are the trends of this market?
โข Which are main factors responsible for new product launch?
โข How big is the global & regional market in terms of revenue, sales and production?
โข How far will the market grow in forecast period in terms of revenue, sales and production?
โข Which region is dominating the global market and what are the market shares of each region in the overall market in 2022?
โข How will each segment grow over the forecast period and how much revenue will these segments account for in 2030?
โข Which region has more opportunities?
By Region Outlook
โข North America
(U.S., Canada, Mexico)
โข Europe
(Germany, France, UK, Italy, Spain, Rest of Europe)
โข Asia-Pacific
(Japan, China, India, Rest of Asia-Pacific)
โข LAMEA
(Brazil, Saudi Arabia, South Africa, Rest of LAMEA)
Contact Details:
David Correa
USA/Canada (Toll-Free): +1-800-792-5285, +1-503-894-6022
[email protected]
About Us
Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of โMarket Research Reportsโ and โBusiness Intelligence Solutions.โ AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.
David Correa
Allied Analytics LLP
+ +1-800-792-5285
email us here
